Clinical TrialID 7890

Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease

NCT05913986

Metabolic Associated Fatty Liver Disease

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7890
Evidence Id
7890
Core Evidence Id
7890
Source Clinical Trial Id
7888
Herb2 Clinical Trial Id
HBCT007888
Nct Id
NCT05913986
Title
Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease
Status
Recruiting
Phase
Study Result
No
Study Condition
Metabolic Associated Fatty Liver Disease
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DIETARY_SUPPLEMENT: LUDLEV®300 mg/46.2 mg|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
50
Outcome Measure
Transitional elastography with Fibroscan, 30 minutes (performed after a 4-hour fast)
Sponsor Collaborator
Saluz Investigación S. C.
Funded By
OTHER
Location
Ana Delfina Cano Contreras, Mexico, Veracruz, 917000, Mexico
Other Id
SaluzInvestigacion
Start Date
2023-03-01
Primary Completion Date
2024-01-10
Completion Date
2024-03-30
First Posted
2023-06-22
Results First Posted
Last Update Posted
2023-06-22
Study Document
Study Protocol, https://cdn.clinicaltrials.gov/large-docs/86/NCT05913986/Prot_000.pdf|Informed Consent Form, https://cdn.clinicaltrials.gov/large-docs/86/NCT05913986/ICF_001.pdf
Study Url
https://clinicaltrials.gov/study/NCT05913986
Title Cn
Title En
Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease
Bilingual Status
semi_complete